Meditoxin, Medytox (100u)
Meditoxin is botulinum A developed by Medy-Tox Korea Limited that approved by KDA on 2004 which had been proved a better effect than Botox The most common complications following injection include bruising at the injection site, mild headache, dry eye, drooping eyelids and uneven look of skin. Most of these results are temporary, undesired effects will fade and then disappear over time.
(100 u)
This is a preview of the recently viewed products by the user.
Once the user has seen at least one product this snippet will be visible.
Once the user has seen at least one product this snippet will be visible.